CMS Drops QRS Restriction From Defibrillator Policy, Requires Registry
This article was originally published in The Gray Sheet
Executive Summary
Guidant will lobby CMS to reconsider the COMPANION CRT-D trial data before finalizing a new implantable cardioverter defibrillator coverage policy